How do you approach a patient with stage IIA non-small cell lung cancer who received SBRT?

Would you offer chemotherapy after radiation is completed?

Answer from: Medical Oncologist at Academic Institution

Well, this is a very challenging question that certainly has come up in discussions at times over the years and I could conclude with a very simple answer: No or could offer a more twisted answer arriving at the same response- just for the fun of it, let’s do the latter.So how would we, as a m...

Comments

Medical Oncologist at The Blavatnik Family – Chelsea Medical Center
Wow, what an elegant response @Balazs!

Radiation Oncologist at Montefiore Einstein Comprehensive Cancer Center
I would just add that surveillance imaging should ...

Medical Oncologist at NYU Winthrop Hospital
@Balazs - Best

Medical Oncologist at UCI Health
@Balazs Halmos Wow, amazing response, and complete...

Radiation Oncologist at Montefiore Einstein Comprehensive Cancer Center
Fantastic

Answer from: Medical Oncologist at Academic Institution

I agree this is definitely a challenge in the field. Obviously, the main issue is the 25-35% of patients who recur in this setting. This highlights the need for the development of validated biomarkers in this space.I will highlight one recent small study by Lebow et al., PMID 37795442 in which they ...

Answer from: Radiation Oncologist at Community Practice

Most of these patients are cured with SBRT. Therefore, off-label adjuvant therapy has medical, ethical, and medical-legal risks. Choose wisely.

Please select the option that best describes you:

How do you approach a patient with stage IIA non-small cell lung cancer who received SBRT?

Related Questions